Proteomic profiling of small number of patients with breast cancer with different subtypes (47) indicated that GLS and TYMS are highest in TNBC (Supplementary Fig. S11G), consistent with the immunoblot data from cell lines (Supplementary Fig. S11E and S11F). The gene discussed is GLS; the disease is breast carcinoma.